|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
9
|
|
pubmed:dateCreated |
2004-12-28
|
|
pubmed:abstractText |
Voriconazole is currently contraindicated for use with sirolimus. We report our experience with voriconazole/sirolimus in two renal transplant recipients. To our knowledge, this is the first experience with voriconazole/sirolimus. An interaction requiring a 75% to 87.5% sirolimus dose reduction was noted, but goal trough levels and clinical tolerability were achieved.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Nov
|
|
pubmed:issn |
0041-1345
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
36
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
2708-9
|
|
pubmed:meshHeading |
pubmed-meshheading:15621130-Adult,
pubmed-meshheading:15621130-Antifungal Agents,
pubmed-meshheading:15621130-Aspergillosis,
pubmed-meshheading:15621130-Aspergillus fumigatus,
pubmed-meshheading:15621130-Candidiasis,
pubmed-meshheading:15621130-Female,
pubmed-meshheading:15621130-Humans,
pubmed-meshheading:15621130-Immunosuppressive Agents,
pubmed-meshheading:15621130-Kidney Transplantation,
pubmed-meshheading:15621130-Lung Diseases, Fungal,
pubmed-meshheading:15621130-Male,
pubmed-meshheading:15621130-Middle Aged,
pubmed-meshheading:15621130-Postoperative Complications,
pubmed-meshheading:15621130-Pyrimidines,
pubmed-meshheading:15621130-Sirolimus,
pubmed-meshheading:15621130-Triazoles
|
|
pubmed:year |
2004
|
|
pubmed:articleTitle |
Combined use of sirolimus and voriconazole in renal transplantation: a report of two cases.
|
|
pubmed:affiliation |
Department of Pharmacy, Saint Barnabas Medical Center, Livingston, New Jersey 07039, USA. smathis@sbhcs.com
|
|
pubmed:publicationType |
Journal Article,
Case Reports
|
